Journal article

The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma

Rhiannon Coulson, Seng H Liew, Angela A Connelly, Nicholas S Yee, Siddhartha Deb, Beena Kumar, Ana C Vargas, Sandra A O'Toole, Adam C Parslow, Ashleigh Poh, Tracy Putoczki, Riley J Morrow, Mariah Alorro, Kyren A Lazarus, Evie FW Yeap, Kelly L Walton, Craig A Harrison, Natalie J Hannan, Amee J George, Colin D Clyne Show all

ONCOTARGET | IMPACT JOURNALS LLC | Published : 2017

Grants

Awarded by NHMRC


Funding Acknowledgements

This research was supported by grants from the National Breast Cancer Foundation and the CASS Foundation (ALC). We acknowledge the support of Victorian Government's Operational Infrastructure Support Program and the National Health and Medical Research Council (NHMRC) of Australia Grants. ALC is supported by an NHMRC Career Development Fellowship (ID 1062247). We also acknowledge funding from the Sydney Breast Cancer Foundation (S.A.O'T), the RT Hall Foundation (S.A.O'T), Tag Family Foundation (S.A.O'T), and the O'Sullivan family (S.A.O'T).